SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMRN: Amarin Corporation plc
AMRN 15.22-2.8%Nov 4 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mkilloran who wrote (3)12/18/2001 1:40:26 PM
From: Mkilloran  Read Replies (2) of 49
 
Corporate Opportunities Group Lowers Amarin Stake To 4.1%


12-17-01 04:20 PM EST

WASHINGTON -(Dow Jones)- A group including Corporate Opportunities Fund LP decreased its stake in Amarin Corp. PLC (AMRN) to 4.1%.

In a filing Monday with the Securities and Exchange Commission, the group said it beneficially holds 2.85 million ordinary shares of the company after selling 3.05 million shares between Sept. 28 and Nov. 30. Financial details weren't provided.

On Sept. 28, the group reported a 9.1% stake in the company.

Amarin is a specialty pharmaceutical company in Ely, England.

-By Phil McCarty, Dow Jones Newswires; 202-862-9251

(This story was originally published by Dow Jones Newswires)

Copyright 2001 Dow Jones & Co., Inc.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext